课题基金 / 基金详情

REGULATORY ELEMENTS OF INTERLEUKIN-2 GENE EXPRESSION

REGULATORY ELEMENTS OF INTERLEUKIN-2 GENE EXPRESSION
INTERLEUKIN-2 基因表达的调控元件
批准号:
3136391
负责人:
JEFFREY A KANT
金额:
$14.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-07-01 至 1990-06-30

项目摘要

项目成果

JEFFREY A KANT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our long-term interest is a better understanding of molecular mechanisms involved T lumphocyte activation and proliferation. In this proposal we focus specifically on defining sequences in the 5'-flanking region of the human interleukin-2 (IL2) gene that participate in IL2 gene expression in normal and leukemic T lymphoid lines and whether trans-acting factors function in these responses. In particular we will examine 1) IL2 gene activation and subsequent down regulation by mitogenes and phorbol esters (PHA/PMA), antibodies to T cell surface antigens T3, T11 and 9.3, and ionophores; 2) inhibition of IL2 expreession by cyclosporina A; 3) cell specific restriction of IL2 expression to certain T lymphoid cells; 4) cycloheximide-mediated superinduction of Il2 mRNA; 5) whether there is species specific IL2 expression in murine and gibbon lymphoid lines, and 6) the potential role of trans-active factors in the apparent lack of normal IL2 expression in the gibbon leukemia line, MLA144. The basic approach will be to test the expression of the bacterial "reporter" enzyme gene chloramphenicol acetyl transferase (CAT) fused to 5'-flanking regions of IL2 (pIL2CAT). We have demonstrated regulatory behavior in these constructs which parallels the endogenous IL2 gene in the mitogen-inducible human T cell line, J32. Mutations constructed in the Il2 5'-flanking sequences of pIL2CAT would permit a comparison of transfected normal and mutant plasmids to define important regulatory sequences. 5' deletions, linker-scanner and site-directed mutants will allow precise delineation of responsible residues. CAT expression data will be supplemented by S1 nuclease protection of CAT mRNAs to confirm that alterations in CAT activity reflect transcriptional regulation of properly initiated "IL2 transcripts." Moreover, competition experiments using cotransfection of normal or altered pIL2CAT with other genes linked to normal or altered IL2 5'-flanking sequences should permit us to determine if trans-acting factors play a role in any Il2 gene responses, a first step toward the isolation and further study of what may be crucial intracellular molecules in a host of regulated gene events. The central role of Il2 in T lymphocyte activation, expansion and other lyumphocyte responses, along with the marked effect on allograft retention of the Il2 inhibitor, cyclosporin A, make the study of Il2 gene expression extremely important for understanding and potentially manipulating immune responses.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Interleukin-2: basic biology and therapeutic use.
Interleukin-2:基础生物学和治疗用途。
DOI: --
发表时间: 1991
期刊: Hematologic pathology
影响因子: --
作者: [Williams,TM, Fox,KR, Kant,JA]
通讯作者: Kant,JA
Two regions within the human IL-2 gene promoter are important for inducible IL-2 expression.
人 IL-2 基因启动子内的两个区域对于诱导型 IL-2 表达非常重要。
DOI: --
发表时间: 1988
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Williams,TM, Eisenberg,L, Burlein,JE, Norris,CA, Pancer,S, Yao,D, Burger,S, Kamoun,M, Kant,JA]
通讯作者: Kant,JA
Retroviral activation of interleukin 2 gene in a gibbon ape T cell lymphoma line.
长臂猿猿细胞淋巴瘤线中白介素2基因的逆转录病毒活化。
DOI: 10.1084/jem.164.5.1723
发表时间: 1986-11-01
期刊: The Journal of experimental medicine
影响因子: --
作者: [Durand DB, Kamoun M, Norris CA, Holbrook NJ, Greengard JS, Crabtree GR, Kant JA]
通讯作者: Kant JA
CORE--MOLECULAR DIAGNOSIS
  • 批准号:
    6217247
  • 项目类别:
  • 资助金额:
    $18.03万
  • 财政年份:
    1999
  • 负责人:
    JEFFREY A KANT
  • 依托单位:
CORE--MOLECULAR DIAGNOSIS
  • 批准号:
    6101804
  • 项目类别:
  • 资助金额:
    $18.03万
  • 财政年份:
    1999
  • 负责人:
    JEFFREY A KANT
  • 依托单位:
CORE--MOLECULAR DIAGNOSIS
  • 批准号:
    6268929
  • 项目类别:
  • 资助金额:
    $18.41万
  • 财政年份:
    1998
  • 负责人:
    JEFFREY A KANT
  • 依托单位:
CORE--MOLECULAR DIAGNOSIS
  • 批准号:
    6236344
  • 项目类别:
  • 资助金额:
    $20.9万
  • 财政年份:
    1997
  • 负责人:
    JEFFREY A KANT
  • 依托单位:
海外基金